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SUNDAY, 29 SEPTEMBER 2013 
 
 
16:00-18:00 Registration and distribution of  
conference material 
 
 
 
 
 
MONDAY, 30 SEPTEMBER 2013 
 
 
09:30–10:30 OPENING SESSION 
 
 
09:30- 10:00  
 D. Mohamad, IAEA 
Deputy Director General 
Head of Department of Nuclear Sciences  
and Applications 
 K. Aning, IAEA 
Deputy Director General 
Head of Department of  
Technical Cooperation 
 R. K. Chhem, IAEA 
Director 
Division of Human Health 
Department of Nuclear Sciences 
and Applications 
 M. Venkatesh, IAEA 
Director 
Division of Physical and Chemical Sciences 
Department of Nuclear Sciences 
and Applications   
 
 
 
 
 
10:00–10:30 
 
 
 
 
 
J. V. Vitola Brazil  OVERVIEW CV Disease: A major threat to Public Health 
1. To illustrate the growing incidence of cardiovascular 
disease across the world and within specific countries. 
2. To demonstrate the value of cardiac imaging in early 
detection of cardiovascular disease and in guiding 
treatment 
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MONDAY, 30 SEPTEMBER 2013 
 
10:30- 12:30 SESSION 1: 
 Current Applications for Cardiac Imaging 
 
Chairperson: R. M. T. Giubbini 
IAEA Coordinator: R. Kashyap 
 
Time Presenter  
Designating Member 
State/Organization 
 Lecture Title and Objectives 
10:30–11:00 
 
 
11:00-11: 30 
 
 
 
11:30-12:00 
 
 
 
12:00-12: 30 
 
P. Smanio 
 
 
A. Jain 
 
 
 
P. A. Kaufmann 
 
 
 
J. Lotz 
 
Brazil 
 
 
AHA 
 
 
 
Switzerland 
 
 
 
ESR 
 
Current Applications for Cardiac Imaging: Nuclear 
Medicine 
To determine the current status and review the clinical 
applications of nuclear cardiology imaging techniques in the 
management of cardiovascular diseases. 
 
Current Application for Cardiac Imaging: 
Echocardiography  
To determine the current status and review the clinical 
applications of Echocardiographic imaging techniques in the 
management of cardiovascular diseases. 
 
Current Applications for Cardiac Imaging: Computed 
Tomography    
To determine the current status and review the clinical 
applications of CT imaging techniques in the management of 
cardiovascular diseases. 
 
Current Applications for Cardiac Imaging: MRI 
To determine the current status and review the clinical 
applications of MR imaging techniques in the management of 
cardiovascular diseases. 
 
 
 
12:30–14:00 Lunch Break 
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MONDAY, 30 SEPTEMBER 2013 
 
14:00–15:30 SESSION 2: 
 ‘How to’ stress my patient  
 
Chairperson: A. Malhotra, India 
IAEA Coordinator: R. Nuñez Miller 
 
Time Presenter  
Designating Member 
State/Organization 
 Lecture Title and Objectives 
14:00–14:20 
 
 
14:20-14:40 
 
14:40-15:00 
 
 
15:00-15:30 
J. Mahmarian 
 
 
J. V. Vitola 
 
S. R. 
Underwood 
 
 
ASNC 
  
 
Brazil 
 
UK 
 
 
Choosing the proper stress test 
To gain an understanding of the various stress modalities 
available and how to choose the proper modality in an 
individual patient. 
 
Pharmacological stress agents and  protocols 
An overview of pharmacological stress, patient preparation and 
protocols including combined exercise and vasodilator stress.  
 
New pharmacological stressor agents 
New A2a receptor agonist pharmacological stressor agents, 
overview and use in special populations 
 
 
Discussion 
 
15:30-16:30 POSTER REVIEW SESSION 1  
 with coffee/tea/refreshments 
 
Location:  Corridor A, B, C: Ground Floor  
 
IAEA Coordinator: T. Pascual 
Poster Reviewers Designating Member State/Organization 
A. Bischof 
Delaloye 
Switzerland 
S. Merlano Gaitán Colombia 
F. Mut Bastos Uruguay 
S. E. Bouyoucef Algeria 
H. Bom ARCCNM  
E. Mishani Israel 
G. L. Dillehay SNMMI 
V.Kumar Australia 
A. Malhotra India 
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MONDAY, 30 SEPTEMBER 2013 
 
16:30-17:50 SESSION 3: READ WITH EXPERTS (RWE) 
 Cardiac imaging techniques in clinical 
 practice 
 
Chairperson: F. Mut Bastos, Uruguay 
IAEA Coordinator: D. Paez 
 
Time Presenter  
Designating Member 
State/Organization 
 Lecture Title and Objectives 
16:30-16:50 
 
 
16:50-17:10 
 
 
17:10-17:30 
 
 
17:30-17:50 
R. M. T. 
Giubbini 
 
B. Elison 
 
 
A. Meave 
 
 
V. R. Lele 
 
 
 
Italy 
 
 
ANZSNM 
 
 
Mexico 
 
 
India 
 
 
 
SPECT 
To develop an understanding of:  
1. Clinical use of SPECT 
2. Pitfalls in usage   
 
CTCA  
To develop an understanding of: 
1. Clinical use of CTCA 
2. Pitfalls in usage 
 
Cardiac MR 
To develop an understanding of: 
1. Clinical use of MR 
2. Pitfalls in usage 
 
PET 
To develop an understanding of: 
1. Clinical use of PET 
2. Pitfalls in usage   
 
 
 
18:00 -20:00 Welcome Reception 
Location:  Corridor A, B, C: Ground Floor 
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TUESDAY, 1 OCTOBER 2013 
 
8:30 - 09:00 SESSION 4:  
 Anatomy, Physiology and biology  
 of coronary arteries 
 
Speaker: E. Alexanderson Rosas, WFNMB 
 
 
 
09:00-10:30 SESSION 5: Cardiac imaging in trials of  
 CAD management   
 
Chairperson:  F. Mut Bastos, Uruguay 
IAEA Coordinator: T. Pascual 
 
Time Presenter  
Designating Member 
State/Organization 
 Lecture Title and Objectives 
09:00-09:20    
 
09:20-09:40 
 
 
09:40-10:00 
 
 
 
10:00-10:30 
S. R. 
Underwood 
 
J. Mahmarian 
 
 
G. Karthikeyan  
 
 
 
 
UK 
 
ASNC 
 
 
India 
 
 
 
 
Clinical trials in chronic coronary artery disease 
Take home messages from recent clinical trials including CE-
MARC, MR-IMPACT2, DIAD, etc. 
 
Clinical trials in acute coronary syndromes  
To increase awareness of the role of cardiac imaging in the 
evaluation of patients with acute chest pain and how recent 
clinical trials (e.g. Romicat, Inspire) can guide patient triage 
and clinical decision-making. 
 
Clinical trials in imaging for coronary revascularization  
To provide a balanced perspective on the role of imaging in 
decisions on coronary revascularization based on a critical 
appraisal of the available evidence from randomized trials e.g. 
STICH, COURAGE, etc. 
  
Discussion 
 
 
 
10:30-11:00 Coffee/Tea Break 
 
 
 
 
To review basic aspects of coronary anatomy and physiology 
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TUESDAY, 1 OCTOBER 2013 
 
11:00-12:30 SESSION 6:Appropriate use criteria for 
 cardiac imaging techniques 
 
Chairperson: J. Mahmarian, ASNC  
IAEA Coordinator: T. Pascual 
 
Time Presenter  
Designating Member 
State/Organization 
 Lecture Title and Objectives 
11:00-11:20 
 
 
 
 
11:20-11:40 
 
 
 
 
 
11:40-12:00 
 
 
 
 
12:00-12:30 
A. Einstein 
 
 
 
 
A. Jain 
 
 
 
 
 
J. Lotz 
ASNC 
 
 
 
 
AHA 
 
 
 
 
 
ESR 
 
The appropriate use of SPECT/PET 
1. Understand the development and application of 
appropriate use criteria and clinical practice guidelines. 
2. Learn common appropriate and inappropriate indications 
for cardiac imaging. 
3. Gain familiarity with the literature on rates of 
appropriateness and strategies to improve 
appropriateness. 
 
The appropriate use of stress echo  
1. Understand the development and application of 
appropriate use criteria and clinical practice guidelines. 
2. Learn common appropriate and inappropriate indications 
for cardiac imaging. 
3. Gain familiarity with the literature on rates of 
appropriateness and strategies to improve 
appropriateness. 
 
The appropriate use of CT and MRI  
1. Understand the development and application of 
appropriate use criteria and clinical practice guidelines. 
2. Learn common appropriate and inappropriate indications 
for cardiac imaging. 
3. Gain familiarity with the literature on rates of 
appropriateness and strategies to improve 
appropriateness. 
  
Discussion 
 
 
 
 
12:30-14:00 Lunch Break 
 
 
8 
  
TUESDAY, 1 OCTOBER 2013 
 
14:00- 15:15 SESSION 7: Customizing imaging and  
 acquisition protocols for CAD Detection  
  
Chairperson:  S. Merlano Gaitán, Colombia 
IAEA Coordinator:  R. Nuñez Miller  
 
Time Presenter  
Designating Member 
State/Organization 
 Lecture Title and Objectives 
14:00-14:20 
  
 
 
 
14:20-14:40 
 
14:40-15:00 
 
15:00-15:15 
 
J. V. Vitola 
 
 
 
 
N. Better 
 
S. E. 
Bouyoucef 
 
 
Brazil  
 
 
 
 
ANZSNM 
 
Algeria 
 
 
 
Current tracers for PET and SPECT: advantages and 
disadvantages 
1. To provide an overview of the basic principles and 
methodologies involving current traces for CAD detection.                                                       
2.  To gain an understanding of customizing the imaging 
general advantages and limitations; pros and cons for 
patient selection). 
 
Optimizing imaging protocols for CAD detection 
1. Overview of currently available imaging protocols 
2. Choosing the optimal protocol for an individual patient 
 
Practicing nuclear cardiology in emerging economies 
How to overcome challenges to the practice of nuclear 
medicine in emerging economies 
 
Discussion 
15:15-16:15 POSTER REVIEW SESSION 2  
 with coffee/tea/refreshments 
 
Location:  Corridor A, B, C: Ground Floor  
 
IAEA Coordinator: T. Pascual 
 
Poster Reviewers Designating Member State/Organization 
A. Bischof 
Delaloye 
Switzerland 
S. Merlano Gaitán Colombia 
F. Mut Bastos Uruguay 
S. E. Bouyoucef Algeria 
H. Bom ARCCNM  
E. Mishani Israel 
G. L. Dillehay SNMMI 
V.Kumar Australia 
A. Malhotra India 
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TUESDAY, 1 OCTOBER 2013 
 
16:15-17:30 SESSION 8: READ WITH EXPERTS (RWE)  
 Recognizing Artefacts and Pitfalls    
 
Chairperson: S. R. Underwood, UK 
IAEA Coordinator:  R. Kashyap 
 
Time Presenter  
Designating Member 
State/Organization 
 Lecture Title and Objectives 
16:15 -16:35 
 
16:35 -16:55 
 
 
16:55 -17:15 
 
 
17:15 -17:35 
R. M. T. 
Giubbini  
 
P. Smanio 
 
 
S. Merlano 
Gaitán 
 
H. Bom 
 
 
 
Italy 
 
Brazil  
 
 
Colombia  
 
 
ARCCNM 
 
Overview of artefacts in nuclear cardiology  
To provide an overview of the artefacts in nuclear cardiology  
 
Recognizing Artefacts and Pitfalls II 
The participants should be able to recognize common 
artefacts and pitfalls in myocardial perfusion SPECT imaging 
and read the scan around them 
 
Recognizing Artefacts and Pitfalls III 
The participants should be able to recognize common motion 
artefacts and pitfalls in myocardial perfusion SPECT imaging 
and read the scan around them 
 
Recognizing Artefacts and Pitfalls IV 
The participants should be able to recognize common 
artefacts and pitfalls in myocardial perfusion SPECT imaging 
and read the scan around them 
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WEDNESDAY, 2 OCTOBER 2013  
 
8:30-09:00 SESSION 9:                     
How to read a coronary angiogram-                                  
Anatomy in context 
 
Speaker:   G. Karthikeyan, India 
 
 
 
09:00-10:30 SESSION I0: Safety Considerations 
 
Chairperson:  S. E. Bouyoucef, Algeria 
IAEA Coordinator:  G. L. Poli 
 
Time Presenter  
Designating Member 
State/Organization 
 Lecture Title and Objectives 
09:00-09:20 
 
 
 
 
09:20-09:40 
 
 
 
09:40-10:00 
 
 
 
 
10:00-10:30 
M. Rehani 
 
 
 
 
P. Kaufmann 
 
 
 
 A. Einstein 
 
 
 
ESR 
 
 
 
 
Switzerland 
 
 
 
ASNC 
 
Radiation burden in Cardiac Imaging 
1. To learn about levels of radiation doses to patients in 
cardiac imaging examinations 
2. To understand radiation burden of cardiac imaging  vis  a 
vis overall radiological exposures to patients 
3. To become familiar with safety implications for individual 
patient radiation burden 
 
Safety of Contrast Agents-CT/MR/Echo 
1. To be aware of the most important contrast agent related 
safety issues 
2. To be able to assess the individual risk 
3. To know strategies to prevent the contrast associated 
risks 
 
Safety concerns in cardiovascular imaging and 
optimization strategies in SPECT and CT 
1. Review safety concerns with drugs used for cardiac 
imaging. 
1. Learn basics of radiation safety. 
2. Survey approaches used to reduce radiation dose in 
SPECT and CT. 
 
Discussion 
 
 
 
10:30-11:00 Coffee/Tea Break 
 
 
 
 
 
An introduction to interpretation of invasive coronary 
angiograms from a diagnostic and treatment perspective 
11 
  
WEDNESDAY, 2 OCTOBER 2013 
 
11:00-12:20 SESSION 11: READ WITH EXPERTS (RWE) 
 Challenging cases - stump the stars  
 
Chairperson:  P. Smanio, Brazil 
IAEA Coordinator:  D. Paez 
 
Time Presenter  
Designating Member 
State/Organization 
 Lecture Title and Objectives 
11:00 -11:20 
 
11:20-11:40    
 
 
11:40-12:00 
 
12:00-12:20  
 
 
S. R. 
Underwood  
F. Mut Bastos 
 
J. V. Vitola 
 
V. R. Lele 
 
UK  
 
Uruguay 
 
 
Brazil  
 
India 
 
 
Challenging Cases I 
A systematic approach to interpretation of common and less 
common nuclear cardiology cases  
 
Challenging Cases II 
Cases on application of nuclear techniques in the diagnostic 
and prognostic assessment of heart failure patients  
 
Challenging Cases III 
Examples of particularly challenging cases with discussion. 
 
Challenging Cases IV 
Review of  challenging cases in Nuclear cardiology 
 
 
 
12:20-13:30 Lunch Break 
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WEDNESDAY, 2 OCTOBER 2013 
 
13:30-15:00 SESSION 12: 
 Physics and Radiochemistry 
 
Chairperson:  V. Kumar, Australia 
IAEA Coordinator:   U. Bhonsle 
 
Time Presenter  
Designating Member 
State/Organization 
 Lecture Title and Objectives 
13:30 -14:00 
 
 
 
 
14:00 -14:30 
 
 
14:30 -15:00 
 
 
 
 
 
G. De Puey 
 
 
 
 
S. Liu 
 
 
E. Mishani 
 
 
 
 
ASNC  
 
 
 
 
USA 
 
 
Israel 
 
 
 
 
 
Hardware and Software for MPI 
1. Describe scintillation camera and software reconstruction 
software advancements that allow for reduce SPECT MPI 
acquisition time and reduced injected activity 
2. Understand how iterative reconstruction, noise reduction, 
and resolution recovery allow for reduce SPECT MPI 
acquisition time and reduced injected activity 
 
New SPECT Radiotracers for Myocardial Perfusion 
Imaging 
Better understanding of new SPECT radiotracers for 
myocardial perfusion imaging  
 
PET MPI imaging agents  
1. Summary of clinically available PET MPI agents  
2. The advantages/drawbacks of PET MPI agents  
3. The current status of potential PET MPI agents which are 
either under clinical trials or preclinical evaluation. 
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THURSDAY, 3 OCTOBER 2013  
 
08:30–09:00 SESSION 13: 
 ECG  Interpretation 
 
Speaker: J. V. Vitola, Italy 
 
 
 
 
09:00-10:30  SESSION 14: Patient Centered Imaging 
 
Chairperson:  A. Bischof Delaloye, Switzerland 
IAEA Coordinator:   R. Kashyap 
 
Time Presenter  
Designating Member 
State/Organization 
 Lecture Title and Objectives 
09:00-09:20 
 
 
 
09:20-09:40 
 
 
 
09:40-10:00 
 
 
10:00-10:30 
 
J. Mahmarian 
 
 
 
G. De Puey 
 
 
 
N. Better 
 
 
ASNC  
 
 
 
ASNC 
 
  
 
ANZSNM 
 
 
 
Patient centered imaging: The Asymptomatic Patient 
1. What is the role of cardiac imaging techniques in 
evaluating asymptomatic patients at risk for coronary 
artery disease. 
2. Who should be imaged and what imaging technique is 
appropriate based on an individual’s clinical risk profile 
 
Patient-Centered Imaging: Symptomatic patient with 
suspected or known CAD 
1. Choose the imaging protocol that will provide the greatest 
diagnostic accuracy and risk-stratification capabilities 
2. Choose the stress modality that will yield the greatest 
diagnostic information 
 
Patient-centred imaging in patients with acute chest pain 
To be able to use nuclear cardiology techniques appropriately 
in high risk groups (e.g. diabetics, vascular patients, pre-op 
evaluation) in triaging patient management. 
 
Discussion 
 
 
 
10:30–11:00 Coffee/Tea Break 
 
 
 
 
 
Basics of ECG – Recognition of patterns that could influence 
nuclear cardiology results 
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THURSDAY, 3 OCTOBER 2013 
 
11:00–12:30  SESSION 15:- Imaging Heart Failure    
 
Chairperson:  A. J. Einstein, ASNC 
IAEA Coordinator: R. Nuñez Miller 
 
Time Presenter  
Designating Member 
State/Organization 
 Lecture Title and Objectives 
11:00-11:20 
 
 
 
 
11:20-11:40 
 
 
11:40-12:00 
 
 
 
12:00-12:30 
J. Lotz 
 
 
 
 
A. Flotats 
Giralt 
 
 
A. Jain 
 
ESR  
 
 
 
 
Spain 
 
 
AHA 
 
 
 
Imaging Heart Failure: The role of CT and MR 
1. Current concepts of imaging the different stages of heart 
failure 
2. Imaging surrogate parameters for diagnosis of subclinical 
and clinically overt heart failure 
3. Prognostic imaging parameters for heart failure 
4. Imaging concepts at the edge of clinical use: Real-time 
imaging and more 
 
Imaging Heart Failure: The Role of SPECT/PET 
A basic understanding of the use of SPECT/PET in patients 
with heart failure. 
 
Echocardiography: advancements in patient imaging, has 
it benefited patient care? 
1. Role of echocardiography in management of heart 
disease  
2. Advances made in technology 
3. How to interpret the results in conjunction with other data 
and improve patient care 
 
Discussion 
 
 
 
12:30–14:00 Lunch Break 
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THURSDAY, 3 OCTOBER 2013 
 
14:00–15:30 SESSION 16: Analyse, interpret,  
 quantify and report 
 
Chairperson:  A. Jain, AHA 
IAEA Coordinator:  D. Paez 
 
Time Presenter  
Designating Member 
State/Organization 
 Lecture Title and Objectives 
14:00-14:20 
 
 
 
14:20-14:40 
 
 
14:40-15:00 
 
 
15:00-15:30 
G. De Puey  
 
 
 
P. A. Kaufmann 
 
 
N. Better 
 
 
 
ASNC  
 
 
 
Switzerland 
 
 
ANZSNM 
 
 
  
 
Image processing, analysis and Interpretation 
1. Systematically view and analyse planar projection images 
and reconstructed tomograms to anticipate and recognize 
artefacts 
2. Combine perfusion and functional information to 
recognize artefacts and improve diagnostic sensitivity and 
specificity 
Quantification and report  
1. To learn the most important methods of quantification in 
nuclear cardiology 
2. To be able to appreciate the clinical impact of 
quantification. 
How to report a Nuclear Cardiology study; integrating all 
information into a final report  
To incorporate the clinical data, exercise data and scintigraphic 
data (perfusion and function) into a final report to answer the 
referring doctor’s question.  
Discussion 
 
15:30-16:30 POSTER REVIEW SESSION 3  
 with coffee/tea/refreshments 
 
Location:  Corridor A, B, C: Ground Floor  
IAEA Coordinator: T. Pascual 
 
Poster Reviewers Designating Member State/Organization 
A. Bischof 
Delaloye 
Switzerland 
S. Merlano Gaitán Colombia 
F. Mut Bastos Uruguay 
S. E. Bouyoucef Algeria 
H. Bom ARCCNM  
E. Mishani Israel 
G. L. Dillehay SNMMI 
V.Kumar Australia 
A. Malhotra India 
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THURSDAY, 3 OCTOBER 2013 
 
16:30-17:50 SESSION 17: READ WITH EXPERTS (RWE)  
 Congestive Heart Failure     
 
Chairperson:  G. De Puey, ASNC 
IAEA Coordinator:  R. Kashyap 
 
Time Presenter  
Designating Member 
State/Organization 
 Lecture Title and Objectives 
16:30-16:50 
 
16:50-17:10 
 
 
17:10-17:30 
 
 
17:30-17:50 
 
 
 
A. Meave 
 
R. M. T. 
Giubbini 
 
 
E. 
Alexanderson 
Rosas 
 
A. Flotats 
Giralt  
 
Mexico 
 
Italy 
 
 
WFNMB 
 
 
Spain 
 
 
Read with Experts- Congestive Heart Failure  
Analysis of the methodical approach in CHF clinical cases 
using MR & CT 
 
Read with  Experts: Congestive Heart Failure II 
An expert opinion on the current use of imaging in congestive 
heart failure using SPECT 
 
Read with Experts:  Congestive Heart Failure III  
Use of PET CT for evaluation of endothelial and coronary 
function as well as myocardial flow. 
 
Read with  Experts: Congestive Heart Failure IV  
Current use of radionuclide imaging techniques in heart failure 
(viability PET vs. SPECT, MIBG,). 
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FRIDAY, 4 OCTOBER 2013  
 
8:30-09:00 SESSION 18: Clinical risk-stratification:  
 role in interpretation of imaging studies  
 and patient management 
 
Speaker: G. Karthikeyan, India   
 
 
 
 
09:00-10:30 SESSION 19: Quality of Practice  
 
Chairperson:  H. Bom, ARCCNM 
IAEA Coordinator:  M. Haji-Saeid 
 
Time Presenter  
Designating Member 
State/Organization 
 Lecture Title and Objectives 
09:00-09:20 
 
 
 
09:20-09:40 
 
 
09:40-10:00 
 
10:00-10:30 
 
K. Bacher  
 
 
 
E. Mishani 
 
 
A. Bischof 
Delaloye 
Belgium  
 
 
 
 Israel 
 
 
Switzerland 
 
 
Quality control in cardiac nuclear medicine and cardiac 
CT  
1. To understand the principles of quality control in cardiac 
CT and cardiac nuclear imaging 
2. To understand the role of the medical physicist in quality 
assurance in cardiovascular imaging  
 
The quality control process of MPI agents  
Understanding the rationale beyond quality assurance and 
control of MPI agents  
 
Quality of practice: Clinical Audit  
To develop a basic understanding of QA and clinical auditing 
in cardiovascular imaging  
 
Discussion 
 
 
 
10:30–11:00 Coffee/Tea Break 
 
 
 
 
To highlight the influence of prior probability estimates derived 
from clinical risk scores on the interpretation of results of 
imaging studies, and their impact on patient management 
decisions 
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FRIDAY, 4 OCTOBER 2013 
 
11:00-12:30 SESSION 20: Hybrid imaging 
 
Chairperson:  A. Bischof Delaloye, Switzerland 
IAEA Coordinator:  A. Duatti 
 
Time Presenter  
Designating Member 
State/Organization 
 Lecture Title and Objectives 
11:00-11:20  
 
 
11:20-11:40  
 
 
11:40-12:00 
 
 
12:00-12:30  
B. Elison  
 
 
E. 
Alexanderson 
Rosas  
 
              
P. A. Kaufmann                             
ANZSNM  
 
 
WFNMB 
 
 
Switzerland
 
 
Hybrid Imaging: SPECT/CT  
1. How does the use of hybrid imaging improve accuracy/ 
specificity of the study 
2. Role of CT attenuation correction and its uses  
3. Changing indications of SPECT/CT imaging  
 
Hybrid Imaging: PET/CT and PET/MR  
To understand the main applications of hybrid techniques in 
heart studies  
 
Image Fusion - promises and pitfalls  
1. Hybrid imaging techniques 
2. Involvement of different specialties and liability issues / 
non cardiac findings.  
 
Discussion 
 
 
 
 
12:30-13:30 CLOSING SESSION   
 
Chairpersons: M. Dondi, IAEA  M. Haji-Saeid, IAEA 
 
 
12:30–13:00 
13:00-13:30 
 
 
 
 
 
J. Mahmarian 
M. Dondi 
ASNC 
IAEA 
 Highlights  
 
Closing ceremony and Poster awards 
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POSTERS 
 
MONDAY, 30 SEPTEMBER 2013 
 
Member State experience with SPECT, PET, 
  echocardiography, CT and MRI in the management of CVDs 
 
 
Location: Corridor A, B, C: Ground Floor 
No of Poster 
IAEA-CN-202- 
Name 
Designating Member 
State/Organization 
 Title of Paper 
A - Member State experience with SPECT, PET,  
echocardiography, CT and MRI in the management of CVDs 
   
103 N. Khelassi-
Toutaoui 
A. Benali  
A. Toutaoui  
et al. 
Algeria  Cardiac CT Patient Dose in Algeria: First Results  
 
104 G. Malhotra 
K. Panchal 
M.V. Reddy 
R.V. Asopa  
et al. 
India  A Study of 4 Minutes versus 6 Minutes Protocol for 
Pharmacological Stress Testing Using Adenosine for Myocardial 
Perfusion Imaging and Comparison with Echocardiography 
Findings 
 
106 F. Alam 
R. Hossain 
A. K. Sarker 
 
Bangladesh  Correlation & Agreement of Measurements of Left Ventricular 
Ejection Fraction by Radionuclide Methods & Echocardiogram 
 
108 M. Josefina Jofré 
Manieu 
 
Chile  Fluordeoxyglucose in the Assessment and Therapy Control of an 
Atrial Angiosarcoma 
 
109 I. Kostadinova 
S.Ivanova 
M.Garcheva 
 
Bulgaria 
 
 Application of SPECT-CT in Patients with Suspicion of a 
Vascular Graft Infection 
 
111 G. Bural 
D. Torigian 
M. Houseni 
A. Alavi 
 
Turkey  FDG Uptake in Large Arteries, Comparison between Genders 
and Correlation with Aging 
 
112 P. Subramanyam 
S. S. Palaniswamy 
 
India 
 
 Implications of Persistent ST Segment Elevation in Q-Wave 
Anteroseptal Myocardial Infarction – Correlation with Myocardial 
Perfusion Gated SPECT 
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No of Poster 
IAEA-CN-202- 
Name 
Designating Member 
State/Organization 
 Title of Paper 
113 P. Subramanyam 
S. S. Palaniswamy 
 
India  Is Exercise Induced ST Depression an Accurate Indicator of 
Viability in Infarct-Related Artery? - A Myocardial Perfusion 
SPECT Study 
 
114 M. Garcheva-
Tsacheva 
I. Kostadinova  
 
Bulgaria 
 
 Influence of Attenuation Correction on the Interpretation of 
Myocardial Perfusion Images 
 
115 A. Dustov 
U. Kurbanov 
M. Mirshahi 
 
Tajikistan 
 
 Dynamics of Myocardial Perfusion with MIBI in Patients with 
Coronary Heart Disease and Post-Infarction Cardiosclerosis after 
Stem Cell Therapy 
 
116 S. J. Gandhi 
S. L. G. Praveen 
S. Padma 
S. S. Palaniswamy 
 
India 
 
 Early Diastolic Dysfunction Detection by 16 bin Gated MPI 
SPECT in End Stage Liver Disease Patients with Normal 
Myocardial Perfusion Undergoing Pre-Transplant Cardiac 
Evaluation 
 
117 S. J. Gandhi 
S. L. G. Praveen 
S. Padma 
S. S. Palaniswamy 
 
India 
 
 Can MPI SPECT Predict Abnormalities on Carotid / Lower Limb 
Doppler USG for Extra Coronary Atherosclerotic Disease 
 
118 S.S. Palaniswamy S. 
Padma 
 
India 
 
 Role of Myocardial Perfusion SPECT in the Prediction of Post-
Surgery Recovery of Ischemic Mitral Regurgitation in Patients 
with Severe LV Dysfunction 
 
119 D. Nariman 
E. Purnomo 
 
Indonesia 
 
 The Correlation between LVEF Gated-SPECT with 
Hemodialysis, Calcium-Phosphorus Product and Parathyroid 
Hormone in Patients with Chronic Kidney Diseases 
 
120 AS. Doğan 
E. İzgi 
ME. Erkan 
M. Aşık 
et al. 
 
Turkey  Correlation between Mean Platelet Volume and Myocardial 
Perfusion SPECT Parameters 
 
121 D. Sobic-Saranovic 
Z. Petrasinovic 
V. Artiko 
V. Obradovic  
 
Serbia  Evaluation of Gated SPECT MIBI Functional and Perfusion 
Abnormalities in Patients with Previous Inferior Myocardial 
Infarction 
 
122 O. Solodiannikova 
N. Golovko 
L. Shevchuk  
 
Ukraine  Possibilities of Echocardiography in Estimation of Cardiotoxicity 
of Chemotherapy in Cancer Patients 
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No of Poster 
IAEA-CN-202- 
Name 
Designating Member 
State/Organization 
 Title of Paper 
123 X. Liu 
J. Yuan 
C. Liu 
J. J. Zaknun 
 
China 
 
 Comparison of Left Ventricular Ejection Fraction between Gated 
Myocardial Perfusion SPECT/CT and Echocardiography in CHD 
patients 
 
124 M. Y. Abbass 
S. A. Shehata 
F. E. Abd El-Samie 
 
Egypt 
 
 Improved Separation of Electrocardiography signals and Mixed 
MR Image by Using Finite Ridgelet Transform 
 
125 V. Agarwal 
 
India 
 
 Does the Thallium Defect Pattern in Myocardial Perfusion 
Scintigraphy Depict the Level of Stenoses in Single Vessel CAD 
Involving the Left Anterior Descending Artery 
 
126 S. Rahabi 
M. Habbeche 
I. Ghedbane 
A. Khelifa 
et al. 
 
Algeria 
 
 Myocardial Infarct in Young Patients: SPECT MPI Findings 
 
127 S.E. Bouyoucef 
S. Rahabi 
M. Habbeche 
I. Ghedbane 
et al. 
 
Algeria  Brain Natriuretic Peptide Correlation Study with SPECT Stress 
and Rest MPI Findings 
 
129 S. Merlano Gaitán 
E. Rodriguez 
R. Murgueitio 
 
Colombia  Proportion of Patients with QRS Greater than 120 msec and 
Normal Phase Gated SPECT MPI Image 
 
130 C. A. Stan 
C. Chirion 
D. A. Stanescu 
D. C Calin 
et al. 
 
Romania  Evaluation of Myocardial Viability with Myocardial Perfusion 
Imaging in Patients with Left Ventricular Aneurysms 
 
133 H. Le Ngoc 
V. P. Lan 
L. M. Ha 
 
Vietnam  Characteristics of Perfusion Defects, Left Ventricular Function 
and Prognostic Value of Early Dipyridamole Tc99m-sestamibi 
Gated SPECT MPI in Post-Myocardial Infarction Patients without 
Primary Angioplasty 
 
134 G. Estrada  
Sánchez 
J. Altamirano 
 
Mexico 
 
 
13N-ammonia Cardiac PET/CT and Coronary CT Angiography 
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136 P. S. Choudhury 
A. K. Chaturvedi 
S. A. Rao 
N. Watanabe 
 
India  Evaluation of a Single Utilization of Pulmonary Perfusion 
Scintigraphy in Patients with Suspected Pulmonary Embolism 
 
138 K. R. Byanyima 
 
Uganda  Diagnostic Reference Levels for Adult Postero-Anterior Chest X-
ray Examination in Kampala, Uganda - A Precursor for the 
National Diagnostic Reference Level 
 
140 G. Priyanka 
L. Vikram 
 
India  Indian Experience with Ultrafast Solid State Detector Dedicated 
Cardiac Camera in Myocardial Perfusion Imaging (MPI) 
 
141 A. F. Apostol 
 
Philippines  The Incremental Prognostic Value of SPECT-MPI in Predicting 
Cardiovascular Events in Patients with Metabolic Syndrome with 
Suspected CAD 
 
142 B. Caliskan 
 
Turkey  Referral Physicians' Indications for Myocardial Perfusion 
Scintigraphy 
 
143 C. T. Mesquita 
S. Garcia 
J. C. de Azevedo 
A. Ribeiro 
et al. 
 
Brazil  Phase Analysis by Gated Tc-99m sestamibi SPECT for Left 
Ventricular Dyssynchrony:  Impact of Myocardial Ischemia. 
 
144 A. P. Quinon 
 
 
Philippines  Correlation between Stress and Rest Left Ventricular Ejection 
Fraction in Gated Single Photon Emission Computed 
Tomography (SPECT) with the Extent and Severity of Perfusion 
Abnormalities 
 
146 I. S. Bandong 
 
Philippines  Positron Emission Tomography versus Cardiac Magnetic 
Resonance Imaging for the Assessment of Myocardial Viability: 
A Meta-Analysis 
 
147 J. I. Arma 
A. Mollerach 
L. Paganini 
V. Jager 
 
Argentina  PET/CT: Uptake Pattern in Prosthetic Heart Valves 
 
148 C. Arroyo Castelán 
J. Z. García 
R. M. Cuaxospa 
 
Mexico  Utility of Myocardial Perfusion Studies for the Re-stratification of 
Risk of Ischemic Heart Disease and its Frequent Risk Factors 
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149 I. Cho  ACCNM  Clinical Experience and Applications of Simultaneous PET/MR 
Imaging in Cardiology 
 
150 A. Elliyanti 
A. H. S. 
Kartamihardja 
 
Indonesia  A Discordance Results between Myocardial Perfusion Imaging 
with Angiography: A Case Report 
 
151 B. Hidayat 
B. Darmawan 
S. Massora 
D. Sonjaya 
 
Indonesia  EF Determination using Tc-99m-Red Blood Cells (RBC) MUGA 
Blood Pool Scintigraphy in the Late Advance Breast Cancer 
(LABC) Cases with Skin Ulcer: A Local Experience 
 
152 P. Orellana Briones 
A. Haeger 
R. Jaimovich 
R. Baeza 
 
Chile  Myocardial Perfusion Scintigraphy and CT Coronary 
Angiography in the Evaluation of Coronary Artery Disease 
 
153 M. Parmar 
 
India  Impact of stress induced 201 Tl gated MPS on LV dyssynchrony 
by phase analysis 
 
154 R. Rasheed Pakistan  TC
99m MIBI SPECT, Single Injection Dual Screening of IHD 
(Silent Myocardial Infarction) and Peripheral Arterial Disease 
(PAD) in Diabetes Mellitus 
 
155 M. Niella 
D. Fino 
F. Gonzalez 
A. A. Astesiano 
et al. 
 
Argentina  Capacity of Steady-State CMR Imaging Sequence for Myocardial 
Necrosis Detection 
 
156 F. Rodrigues  Filho 
J. Soares Jr 
M. lzaki 
M. C. P. Giorgi 
et al.  
 
Brazil  Influence of a Low-Carbohydrate Diet on the Assessment of 
Myocardial Viability with 18F Fluorodeoxyglucose PET: 
Comparison with the Euglycemic Hyperinsulinemic Clamp 
 
157 G. Khachatryan 
K. Khondkaryan 
 
Armenia  Myocardium State and Ventricle Perfusion Features in Civil 
Aviation Flying Personnel 
 
159 A. Sood 
 
India  Role of [13N] NH3-[18F] FDG PET/CT in Predicting the Outcome 
in Patients with Coronary Artery Disease 
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160 M. Ait Idir 
A. Guensi 
S. Taleb 
F. Chabraoui 
et al. 
 
Morocco  Myocardial Ischemia in Patients with Diabetes: Contributions of 
Myocardial Perfusion Imaging 
 
161 I. S. Bandong 
 
Philippines  Prognostic Value of Thallium ECG-gated Myocardial Perfusion 
Single-Photon Emission Computed Tomography (SPECT) Left 
Ventricular Parameters in Patients with Suspected Coronary 
Artery Disease 
 
165 R. Yudistiro 
 
Indonesia  Myocardial Perfusion Scan (MPS) Results in Asymptomatic 
Patients with Coronary Artery Disease (CAD) Risk Factors 
 
166 J. S. González 
Araya 
 
Chile  99mTc-sestamibi Exercise SPECT and Follow-up in Patients 
Able to Reach 10 Metabolic Equivalents of Task (METs) 
 
167 E. Lemos Pereira 
L. Oliveira 
M. Fernandes 
P. Colarinha 
 
Portugal  Feasibility of ECG-gated at Myocardial Perfusion Studies: is it 
Worthy to ECG-gated at both Stress and Rest 
 
168 M. Mouloudi 
T. Bassaid 
N.  Kriou 
A. Boubendir 
et al. 
 
Algeria  The Place of Cardiac Computed Tomography Angiography 
(CCTA) in Cardiac Pathology 
 
170 J. C. Manrique-Arias 
V.M. Lara-Camacho 
M. Avila-Garcia 
A. Flores-Moreno 
et al. 
 
Mexico  Preparation and Preclinical Evaluation of [
64Cu]Cu(II)-PTSM: A 
Tracer for Myocardial Perfusion  
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171 S. Sidibé 
S. Traoré 
R. Diakité 
 
Mali  Evaluation of Left Ventricular Function in Mali using a 
Radionuclide Method: Application, Methodology and Normal 
Values 
 
172 A. Puente 
J. Morales 
G. Meléndez  
 
Mexico  Gated SPECT Functional Assessment in Obese Patients 
 
174 P. K. Huynh 
X. Q. Truong  
 
Vietnam  Rest Thallium-201/Stress Technetium-99m sestamibi Dual-
Isotope Myocardial Perfusion Single-Photon Emission Computed 
Tomography in Detecting of Chronic Coronary Artery Disease 
 
175 K. Khan 
Jielani 
Ayub 
Abbasi 
et al. 
 
Pakistan  Sodium Bicarbonate Augmented 
201Tl Rest/Redistribution 
Myocardial Perfusion SPECT in Detecting Myocardial Viability 
 
177 S. Afroz 
 
Bangladesh  Gated SPECT Imaging for Evaluation of Coronary Artery 
Disease - Experience in a Developing Country 
 
178 O. Diop 
S. Seck Gassama  
E. H. L. Bathily 
G. A. Kabre 
et al. 
 
Senegal  Challenges in Nuclear Cardiology in Senegal 
 
179 M. Mbodj 
O. Diop 
B. Ndong 
E. H. L. Bathily 
et al. 
 
Senegal  Evaluation of Coronary Artery Disease Using Stress ECG and 
Myocardial Perfusion Imaging in a Developing Country  
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180 
 
S. Seck Gassama 
O. Diop 
B. Ndong 
E. H. L. Bathily 
et al. 
 
 
Senegal 
  
Experience with Performing Myocardial Perfusion Imaging (MPI) 
in Ischemic Heart Disease in Senegal  
 
183 K. Myint 
 
Myanmar  Nuclear Cardiology Status in Myanmar 
 
184 G. Fadragas 
 
Cuba  Prognostic Value of Myocardial Perfusion Test with 99mTc-MIBI 
in Symptomatic and Asymptomatic Patients with Coronary Risk 
Factors 
 
186 M. Montecinos 
Santibanez, 
M. Mera 
S. Lapresa 
M. Casal 
et al. 
 
Argentina  Usefulness of Assessment of Coronary Reserve Flow in a 
Patient with Coronary Multivessel Disease 
 
187 S. Voo 
M. Kemna 
P. van Paassen 
J. W. Cohen-Tervaert 
et al.  
 
Netherlands  18F-FDG PET-CT Imaging for the Evaluation of Small- and 
Medium-size Vessel Vasculitis 
 
188 M. Havel 
O. Kraft  
 
Czech Republic 
 
 Comparison of Myocardial Perfusion SPECT Acquired with 
Linear Energy High Resolution Collimators (LEHR) and 
SMARTZOOM Collimators, Automatic Quantitative Software 
Differences 
 
189 L. Henzlová 
M. Kamínek 
I. Metelková 
M. Budíková 
et al 
 
Czech Republic 
 
 Combination of Myocardial Perfusion SPECT with Calcium Score 
Measurement Improved the Detection of Ischemic 
Cardiomyopathy 
 
190 A.Y. Chambi 
Cotrado 
 
Brazil 
 
 Myocardial SPECT CT: Evaluation of Calcium Score during 
Perfusion SPECT Adds Diagnostic and Prognostic Data 
 
191 C. C. Wiefels 
S. Garcia 
J. C. de Azevedo 
A. Ribeiro 
et al. 
 
Brazil 
 
 Evaluation of Cardiac Synchronism by GATED SPECT: Impact 
of Myocardial Fibrosis 
 
27 
  
192 
 
 
F. Faccio 
 
 
Argentina  Predicting Variables of Abnormal Myocardial Perfusion (MP) in 
Asymptomatic Patients 
194 C. J. Trauernicht 
T. Kotze 
R. Steyn 
J. Boniaszczuk 
 
South Africa  Phantom Study of Myocardial Perfusion SPECT-CT 
 
195 K. Purbhoo 
 
South Africa  Efficacy of Full Fat Milk versus Diluted Lemon Juice to Reduce 
Interfering Infra-Cardiac Activity of Tc-99m Sestamibi during 
Myocardial Perfusion Imaging 
 
196 C. Martínez 
G. Solis 
D. López 
A. Puente 
 
Mexico  Changes in Myocardial Perfusion in Patients Undergoing Cardiac 
Resynchronization 
 
198 D. Vajauskas 
A. E.Tamošiūnas 
 
Lithuania  Cardiac Adrenergic Innervation Imaging Assessed with SPECT: 
Imaging Beyond Planar Cardiac Adrenergic Innervation Scan 
 
199 O. Moskalets 
Y. Kmetyuk 
O. Bondaruk 
A. Ashykhmin 
 
Ukraine  Abnormalities of Myocardial FDG Uptake during Routine 
Oncology Positron Emission Tomography Studies 
 
200 A. Al-Shammari 
R. Ashkanani 
S. Alabsi 
S. Alenezi 
et al. 
 
Kuwait  F18-FDG PET/CT in Assessing Myocardial Viability: First Kuwait 
Experience  
 
202 I. Berrocal Gamboa, 
C. Fonseca 
M. Torres 
J. Salas 
et al. 
 
Costa Rica  Prone Myocardial Perfusion SPECT Additional Imaging: Review 
of Results vs. Supine in the Interpretation 
 
203 N. Zafrir 
 
Israel  Myocardial Perfusion Imaging with Half the Radiation Dose using 
Conventional Gamma Camera 
 
204 A. A. Chaname 
Abad 
 
 Peru  Usefulness of the Study of Myocardial Perfusion with 
Dipyridamole in Clinical Practice 
 
205 M. R. Mititelu 
C. Mazilu 
 
Romania  Myocardial Perfusion Imaging in Patients with Diabetes Mellitus 
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206 A. Haeger R. 
Jaimovich 
P. Orellana 
JC. Quintana 
et al  
Chile  Usefulness of SPECT-CT in myocardial perfusion studies 
 
214 R. W. Lopes 
I. M. F. Pinto 
L. E. Mastrocola  
F. B. P. Alves 
 
Brazil  Assessment of Suspected Coronary Arterial Disease using 
Myocardial Perfusion Scintigraphy (SPECT) Combined with 
Multi-Detector Computed Tomography in a Brazilian Population 
 
215 J. P. Zhindon 
Pacurucu  
 
Chile  Importance of Adequate Quality Control of Left Ventricular 
Boundaries with Commercial Software in Gated Myocardial 
Perfusion SPECT: Analysis of Patients with Ventricular Dilation 
and Myocardial Infarction 
 
216 L. T.D. P.   
Massardo Vega 
 
Chile  Assessment of Peripheral Neuropathy and Microalbuminuria in 
Coronary Asymptomatic Patients with Diabetes Mellitus Type 2 
related with Myocardial Stress Perfusion Abnormalities 
 
217 H. Shacham 
Suchman 
A. Aharon 
V. Kulikov 
E. E. Sapir 
 
Israel  FDG  – PET/CT for Assessment of Abdominal Aortic Infection with 
and without Graft :Experience in a Single Tertiary Medical 
Center 
 
218 J. R. Gómez Garibo 
J. Serna 
S. Paredes  
 
Mexico  Myocardial Viability: Comparison between Studies 
Thallium/SPECT and FDG/PET 
 
219 M. Zdraveska 
Kochovska 
V. Majstorovl  
D. Pop Gjorceva  
et al. 
 
Former Yugoslav 
Republic of Macedonia 
 Artefacts in SPECT Myocardial Perfusion 
 
220 H. Le Ngoc.  
Le M. Ha 
 
Vietnam  Value of Gated SPECT Myocardial Perfusion Imaging with and 
without Attenuation Correction in Diagnosis of Coronary Artery 
Disease 
 
221 B. Izić 
A. Jakubović 
Čičkušić 
M. Sulejmanović 
 
Bosnia and 
Herzegovina 
 
 The Value of Tc-99m MIBI SPECT during Nitrate Administration 
in Assessment of Viable Myocardium in Patients with Dilated 
Cardiomyopathy 
 
223 I. Garty  
J. Schurman 
 
Israel  The Use of Atropin in Exercise Myocardial Perfusion 
Scintigraphy: Can It Improve the Study Diagnosis Accuracy 
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224 L. O. Cabrera 
Rodriguez 
A. Peix 
K. Padrón 
R. Carrillo  
et al. 
 
Cuba  Value of Normal Myocardial Perfusion Images Compared with 
Non-coronary Stenosis Determined by Coronary Angiographic 
for One Year Prognosis 
 
225 L. O. Cabrera 
Rodriguez 
K. Padrón 
A. Peix 
J. A. García  
et al. 
 
Cuba  Is Mechanical Dyssynchrony Related to Myocardial Viability: 
Simultaneous Evaluation with Gated-Single Photon Emission 
Computed Tomography 
 
226 M. A. Pineda Tovar 
A. Ortega Ramirez 
J.S.  Valencia 
Sánchez 
et al. 
 
Mexico 
 
 Case Report: Gated Tetrofosmine Myocardial Perfusion Image 
Showing Ligth Ischemia in Presence of Multi-Vessel CAD 
 
228 M. Makoso Baduka 
F. Peeters 
V. Lukanda Mwamba 
V. Tsimba Tsasa 
et al. 
 
Democratic Republic of 
Congo 
 
 MRI: Diffusion Tensor Imaging using a Bi-Exponential Model 
 
229 R. J. Cerci 
M. Zapparoli 
F. R. Farias 
S. S. Zier 
et al. 
 
Brazil  Coronary Computed Tomography Angiography as a Gatekeeper 
for Invasive Angiography in Patients with Mild Ischemia by 
SPECT-MPI in a Developing Country 
 
230 K. Miranda 
Fernandez 
 
Bolivia  Identification of Myocardial Viability Post-Nitrates: an Initial 
Experience in a Bolivian Center 
 
231 A. C. Jiménez 
A. Alfaro 
G. Castro 
K. Calvo 
 
Costa Rica  False Positive in Myocardial Perfusion SPECT Due to Left 
Bundle Branch Block Artefact 
 
232 M. Kapitán Otero 
A. Negrin 
D. Bia 
M. Lujambio 
et al. 
 
Uruguay  Cardiac and Vascular Effects of Chronic Cocaine Abuse in 
Young Asymptomatic Subjects 
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234 R. Gutterres 
A. Oliveira 
P. Crisóstomo 
M. Cardona 
et al. 
 
Brazil  Identification of Cardiac High Risk Female Patient Profile 
 
235 R. Gutterres 
A. Oliveira 
P. Crisóstomo 
M. Cardona 
et al. 
 
Brazil  Assessment of Attenuation Correction Effects in Image Quality of 
Myocardial Perfusion Scintigraphies 
 
236 R. Gutterres 
A. Oliveira 
N. Monerat 
M. Cardona 
et al. 
 
Brazil  Breast Attenuation Impact on Anatomic Functional Correlation of 
Myocardial Perfusion Scintigraphy and Coronary Angiography 
 
237 F. Mut Bastos 
E. Besada 
A. Beltrán 
A. Panzacchi 
et al. 
 
Uruguay  Myocardial Viability Studies with PET-FDG Associated with 
Multislice CT Coronary Angiography: Initial Experience in 
Uruguay 
 
239 A. N. K.  
Al-Ibraheem 
Z. Alrababa  
 
Jordan  Evaluation of Left Ventricle Ejection Fraction in Oncologic 
Patients; Comparison of Resting Planar Radionuclide 
Ventriculography and Resting Gated Myocardial Perfusion 
SPECT Techniques 
 
240 P. Mohan 
U. Kaul 
R. Gupta 
H. Mahajan 
 
India  A Comparative Analysis of Myocardial Perfusion on Gated 
SPECT Versus Coronary Atherosclerosis and Calcium Score on 
64-Slice CT 
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A - Member State experience with SPECT, PET,  
echocardiography, CT and MRI in the management of CVDs  
 
241 I. Tahirou 
I. D. J. Moussa 
A. Ada 
I. Djeomboro 
et al. 
 
Niger  Contribution of Myocardial Perfusion Imaging in Cardiovascular 
Disease in Countries with Limited Resources 
 
244 E. Slobina 
N. Maroz-
Vadalazhskaya  
 
Belarus  Imaging-based Cancer Patient Management by Using US and 
MRI in Oncologic Imaging of Cardiovascular System 
 
245 AS. Doğan 
ME. Erkan 
M. Aşık 
A. Yılmaz 
et al. 
 
Turkey  Metabolic Syndrome Indicates Larger Stress Defect Score on 
GATED SPECT 
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246 AS. Doğan 
M. Aşık 
ME. Erkan 
A. Yılmaz 
et al. 
 
Turkey  Relationship between Insulin Resistance and Myocardial 
Perfusion SPECT Parameters 
 
247 AS. Doğan 
ME. Erkan 
M. Aşık 
A. Sarıtaş 
et al. 
 
Turkey  Tc-99m Setamibi Detects Carbon Monoxide Poisoning 
 
248 N. Maroz-
Vadalazhskaya 
O. L. Polonetcki 
E. L. Slobina 
et al. 
 
Belarus  MRI and Cardiac Ultrasound Utilities in Patients with Acute 
Myocardial Infarction and No-Reflow Phenomena Early after 
Invasive Coronary Reperfusion 
 
249 M. Agolti 
A. Amin, 
A. Rodriguez 
 
Argentina 
 
 Characterization of Patients Identified as High Risk in Gated 
SPECT Myocardial Perfusion Imaging 
 
250 M. H. G. Baghdadi 
 
Iraq 
 
 The Role of CT in Diagnosing Congenital Heart Diseases in Iraq 
 
251 A. S. A.   
Al-Breesam 
 
Iraqs  The Acute in Hospital Outcomes of PCI in Ibn-Albetar Hospital 
 
252 S. Synefia  
 
Greece  Index of Quantification of Volume Differences in 3D SPECT 
Stress / Rest Images 
 
256 A. Klaipetch 
S. Namwongprom 
T. Kaewchur 
W. Teeyasoontranon 
J. Srirattanasak 
 
Thailand 
 
 Myocardial Perfusion Abnormality on SPECT MPI and 
Abdominal Aortic Calcification Detected by DXA 
 
257 S.S. H. Mohamed 
H. Al Dhuhli  
A. K. Maher Ali 
 
Oman 
 
 Correlation of Myocardial Perfusion Imaging and Computed 
Tomography Coronary Angiography for the Assessment of 
Coronary Arteries Disease: SQUH Experience 
 
259 M. Dereli Turkey  Conventional Angiography Imaging of Post-traumatic 
Pseudoaneurysm of the Superficial Femoral Artery 
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260 L. N. Singh 
M. Tamang 
R. Shaha Chaudhary 
 
Nepal  Prospect of Cardiac Imaging Necessity in B. P. Koirala Memorial 
Cancer Hospital 
 
263 C-B. Bui 
G-C. Chau 
M. A. H. Nguyen 
T-S. Vo 
et al. 
 
Vietnam  Using Non-Invasive Assays To Improve Detection Of Oxidized 
Low Density Lipoproteins (Ox LDDL) In Atherosclerosis 
B - Use of hybrid imaging or integrated imaging in  
CVD management 
 
  
128 W. Dong 
Q. Wang 
J. Jiao 
S. Gu 
et al. 
 
China 
 
 Clinical Value of Cardiac Hybrid SPECT/CTA Imaging on 
Management Strategies in CAD 
 
132 R. A. Rasata 
 
Madagascar 
 
 Comparative study by ultrasound and isotopic method for the 
assessment of left ventricular ejection fraction in Madagascar 
 
135 J. Altamirano Ley 
G. Estrada 
 
Mexico 
 
 Multimodality Imaging for Assessment of Heart Failure Patients 
in a PET/CT Center: 13N-ammonia, 18FDG, Coronary CT 
Angiography and Calcium Score 
 
139 F. Z. T. Huber,  
W. E. F. M. Alves,  
M. J. Santos,  
E. T. Rocha 
 
Brazil  Radionuclide Ventriculography in the Evaluation of Cardiotoxicity 
by Chemotherapy 
145 A. Morales, Jr. 
A.F. Samiling 
 
Philippines  Acceptance Testing of a Hybrid Operating Room in the 
Philippines 
 
162 H. K. A. Mahmoud 
 
Egypt  Automated Diagnosis of Nuclear Cardiac Images Using 
Advanced Digital Image Processing Techniques 
 
164 S. Haider 
F. Gillani  
 
Pakistan  Dual energy X-ray Absorptiometry Can Assess Cardiometabolic 
Risk in Different Body Mass Indices 
 
173 A. S. Pallewatte  
 
Sri Lanka  Evaluation of Integrated Medical Imaging for Congenital Aorto-
Cardiac Anomalies in Tertiary Referral Centers in Sri Lanka (with 
Special Emphasis on Paediatric CT and Radiation Exposure) 
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176 Z. M. Jawa 
A. Isa 
S. Lawal  
 
Nigeria 
 
 Potential Benefits of Equilibrium Radionuclide Angiography in 
HIV-related Cardiac Disorders 
 
201 H. Bom 
H. S. Kim 
S. G. Cho 
 
ARCCNM  Correlation of Myocardial Blood Flow and Flow Reserve to 
Anatomical Lesions using Hybrid PET/CT 
 
233 R. Campisi 
N. Aramayo 
A. R. Osorio 
R. J. Geronazzo 
et al. 
 
Argentina 
 
 Relationship between Myocardial Viability and Coronary 
Anatomy in Patients with Left Ventricular Dysfunction as 
Assessed by Positron Emission Tomography Integrated to 
Multidetector Computed Tomography 
 
238 A. S. Naojee 
 
Mauritius  Establishing Nuclear Cardiology Practice with Integrated Imaging 
in Mauritius and the Difficulties Encountered 
 
243 M.F. Bozkurt 
E.L. Ergün 
Ö. Uğur 
 
Turkey  Value of Hybrid Imaging-Based Attenuation Correction in the 
Diagnostic Work-up of Myocardial Perfusion Scintigraphy 
 
253 N. Ben Rais 
 
Morocco  Perfusion Scintigraphy and Hybrid Imaging in the Diagnosis of 
Pulmonary Embolism in Pregnancy 
 
254 N. R. Stevenson 
G. Gonzales 
J. Simon 
S. Srivastava 
et al. 
 
United States 
 
 Manufacturing and Integrated Medical Imaging of High Specific 
Activity [Sn-117m]-Annexin in Cardiovascular Disease 
 
261 
 
 
 
M. A. A. Abu Saiba 
 
 
Iraq 
 
 Update of Integrated Medical Imaging in Cardiovascular 
Diseases 
 
D - Radiopharmaceutical production using cyclotrons and 
radionuclide generators - including good manufacturing 
practice and quality assurance aspects - with special 
reference to imaging agents for CVDs 
 
  
105 A. Malhotra 
K. Praveen 
C. D. Patel 
B. S. Pathania 
 
India  Production & Quality Assurance of 
13 NH3 Ammonia in a Busy 
PET –CT Centre for Myocardial Viability Studies 
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181 R. S. Senghor 
S. Seck-gassama 
M. Mbodj 
 
Senegal  Challenges in Radiopharmacy in Nuclear Cardiology in Senegal 
 
182 R. S. Senghor 
L. Dieng 
M. Diarra 
S. Seck Gassama 
 
Senegal  Performance of the Ultratechnekow Generator in Nuclear 
Cardiology in Senegal 
 
242 E. H. Has 
A. Tanrikut 
A. N. Yuksel 
S. Unal 
et al. 
 
Turkey 
 
 TAEA-PAF Produced Radioisotopes and Radiopharmaceuticals 
for Cardiovascular Diseases 
 
E - Issues of medical physics, instrumentation and image  
processing and analysis related to CVD imaging  
  
 
212 P. Orellana  Briones 
R. Jaimovich 
L. Marine 
A. Krammer 
et al. 
 
Chile  Sn117m-DOTA-Annexin as a novel vulnerable plaque tracer. 
First time in humans trial.  
 
F - Quality management, quality control, quality assurance 
and audits in integrated medical imaging and nuclear 
medicine practice  
 
  
102 N. Khelassi-
Toutaoui 
A. Merad 
A. Toutaoui 
et al. 
 
Algeria  Patient Dose Assessment in Interventional Cardiology 
Procedures in Algeria 
 
131 N. Ben Rais 
 
Morocco  Improvement of Nuclear Cardiology in Morocco 
 
158 D. H. Salama
  
A. M. Badawi   
 
Egypt 
 
 Image Quality and Radiation Dose using Low Tube Kv in ECG 
Gated 64 Slice CT Coronary Angiography 
 
163 A. Hovhannesyan 
D. Ohanyan 
A. Khachatryan 
 
Armenia 
 
 Myocardial Quantitative Gated SPECT in Optimization of Device 
and Patient Selection 
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169 S. Moussouni 
T. Bassaide 
H. Mahmoudi 
N. Merzougui 
et al. 
 
Algeria  Pulmonary Embolism: Diagnostic Strategies 
 
193 A. Skopljak-
Beganović 
B. Hanić 
A. Beganović 
et al. 
 
Bosnia and 
Herzegovina 
 
 Estimation of Effective Doses for Patients in Interventional 
Cardiology 
 
197 A. M. Prata 
Jeronimo 
A.I. Santos 
I. Henriksson 
H. Pereira 
 
Portugal  Appropriate Use Criteria for Cardiac Radionuclide Imaging - 
Compliance and Relationship to Clinical Impact 
 
206 A. Haeger 
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